Medtronic’s (NYSE:MDT) AdaptivCRT self-regulating defibrillators may help take a chunk out of healthcare costs by slashing certain follow-up care for patients with heart failure, according to the latest results from an ongoing analysis.
Minnesota
UPDATE: FDA panel issues mixed vote on EnteroMedics weight-loss implant
Op-ed: Medtronic/Covidien deal good for patients, Minnesota
By: Shaye Mandle, President & CEO, LifeScience Alley
LifeScience Alley, the nation’s largest regional life science industry association, welcomes the news that Medtronic, the world’s leading provider of medical technology products, services and solutions, is acquiring Covidien, a leading global healthcare technology and medical supplies provider.
Medtronic’s OUS move becomes a political football | MassDevice.com On Call
Diabetes: Medtronic and Sanofi ally on new drug-device combinations
Analysis: What does the union of Medtronic and Covidien mean for medtech?
By Brad Perriello and Brian Johnson
UPDATED June 16, 2014, with additional comment from Leerink Partners analyst Danielle Antalffy.
Independent legal panel rejects Infuse allegations in Medtronic shareholder suits
Ishrak: Medtronic needs to get smart about emerging markets
Medtronic has a bit of a growth problem in emerging markets, and throwing money at it isn’t making it go away.
Medtronic wants candidates for $20k patient innovator award | MassDevice.com On Call
Medtech gets a nod in Minnesota’s Super Bowl pitch | MassDevice.com On Call
MASSDEVICE ON CALL — The Minnesota Vikings highlighted some of their state’s most prominent features in order to win over the Super Bowl selection committee, including some of the North Star State’s most prominent medical device makers.